有害事象報告詳細
| VAERS ID | 1425326 |
|---|---|
| 性別 | 女性 |
| 年齢 | 36歳 |
| 州コード | FR |
| 製薬会社 | ファイザー |
| ロット番号 | EW4109 |
| ワクチン接種回数 | 2 |
| 接種日 | 2021-04-05 |
| 発生日 | 2021-04-05 |
| 状態 | 入院 回復 |
症状
- 関節痛(Arthralgia)
- 発熱(Pyrexia)
- 頭痛(Headache)
- 寒気(Chills)
- 痛み(Pain)
- 筋肉痛(Myalgia)
- 目の痛み(Eye pain)
- 敏感肌(Sensitive skin)
- 体温(Body temperature)
- 妊娠中の母親の曝露(Maternal exposure during pregnancy)
罹患中の病気
持病
その他医療
以前のワクチン接種
アレルギー
臨床検査
Test Date: 20210405; Test Name: body temperature; Result Unstructured Data: Test Result:greater or equal to 38 C degrees Centigrade
症状詳細
Fever greater or equal to 38 C degrees; headache; chills; pain; sensitivity; myalgia; arthralgia; retroocular pain; Gestation week: 5; This is a spontaneous report from a non-contactable other health professional.
This is a report received from the Regulatory Authority via email.
Regulatory authority report number is 14487-6.
This other hcp reported information for both mother and fetus.
This is the maternal report, no fetus case was created due to no adverse event was reported for the fetus.
A 36-year-old female pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular, administered in arm left on 05Apr2021 (at the age of 36 years old) (Lot Number: EW4109; Expiration Date: 01Jul2021) as dose 2, single for COVID-19 immunisation.
The patient medical history and concomitant medications were not reported.
Patient was healthy before vaccination.
No allergies history.
The patient experienced gestation week: 5 on 05Apr2021, fever greater or equal to 38 c degrees (hospitalization) on 05Apr2021, headache (hospitalization) on 05Apr2021, chills (hospitalization) on 05Apr2021, pain (hospitalization) on 05Apr2021, sensitivity (hospitalization) on 05Apr2021, myalgia (hospitalization) on 05Apr2021, arthralgia (hospitalization) on 05Apr2021, retroocular pain (hospitalization) on 05Apr2021.
The mother reported she became pregnant while taking bnt162b2.
The mother was 5 weeks pregnant at the onset of the event.
Clinical course: Patient went to the HCF on 05Apr2021 with headache, myalgia, arthralgia.
Referred to have 5 weeks of gestation when she was hospitalized and the study notification was made.
She was stable and under observation.
Treatment received included tramadol intravenous, paracetamol tablets 1 gram, ketorolac 30mg intramuscular and ibuprofen 200mg orally.
Treatment received before receiving medical attention which included paracetamol.
The outcome of the events was recovered.
No follow-up attempts are possible.
No further information is expected.